We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Myalgic encephalomyelitis or chronic fatigue syndrome is a chronic, complex and multisystemic disease that can significantly affect functional capacity and daily life. It is characterised by debilitating fatigue that does not improve significantly with rest, post-exertional malaise, sleep disturbances and cognitive difficulties.
The cause of chronic fatigue syndrome is not yet fully understood, and its pathophysiology remains the subject of ongoing research. Possible mechanisms and predisposing factors are being investigated, including neurological, metabolic and immune system abnormalities, as well as a possible genetic contribution. Available genetic studies have produced preliminary findings and do not yet allow a definitive genetic basis for the condition to be established. Infections have also been linked to the onset of some cases, although the mechanisms involved are not yet fully understood.
Clinical assessment should take into account the full range of symptoms and how they develop over time, including post-exertional malaise, sleep disturbances, cognitive difficulties, pain and possible autonomic and immune system manifestations. Management aims to provide individualised care, control symptoms and improve quality of life, taking into account each person's needs and abilities.
Chronic fatigue syndrome is characterised by a range of symptoms that can vary in intensity and frequency between affected individuals and over time. The main symptoms include debilitating fatigue that does not improve substantially with rest and significantly reduces the ability to carry out everyday activities, post-exertional malaise, unrefreshing sleep and cognitive difficulties.
Post-exertional malaise is the worsening of symptoms following physical, cognitive, emotional or social activities that were previously better tolerated. This worsening may be disproportionate to the activity undertaken, may be delayed (occurring hours or even days afterwards) and may last for days or longer.
Other symptoms may include:
The condition can affect people of any age, including children, adolescents and adults. In adults, it is diagnosed more frequently in women than in men, although it can affect people of any sex.
The prevalence of the condition varies depending on the diagnostic criteria used and the methodology of epidemiological studies. It is also thought to be significantly underdiagnosed, meaning that prevalence estimates may not reflect the actual number of people affected. When interpreting these figures, it is important to take into account the population studied and the criteria used in each study.
Diagnosis is clinical and is based on an assessment of the symptoms, how they develop over time and their impact on functional capacity. There is currently no laboratory or imaging test that can, on its own, confirm the condition.
Further investigations are selected on an individual basis according to each person's clinical presentation. Their purpose is to support the diagnostic assessment, investigate other conditions that may explain the symptoms and identify any coexisting conditions.
Myalgic encephalomyelitis should be suspected in people who experience debilitating fatigue that does not improve substantially with rest, a significant reduction in their ability to carry out everyday activities, post-exertional malaise, unrefreshing sleep or other sleep disturbances, and cognitive difficulties. The diagnosis can be confirmed when symptoms have persisted for three months, established diagnostic criteria are met and no other clinical explanation for the symptoms is identified.
The assessment should include a detailed medical history, a physical examination and an assessment of mental state when clinically indicated. It is important to establish when the symptoms began and how they have developed, their impact on everyday life, whether post-exertional malaise is present and whether there are other associated symptoms, as well as to identify any possible coexisting conditions.
Treatment
There is currently no curative treatment for this condition. Management should be individualised and, where possible, interdisciplinary. It should focus on controlling the main symptoms, preventing them from worsening and improving quality of life, taking into account the severity of the condition and each person's needs.
The main care measures include:
Clinical follow-up should be adapted to the severity and progression of the condition, with decisions made jointly by the person and their healthcare professionals.
Graded exercise therapy based on fixed, predetermined increases in physical activity is not recommended.
Prevention
No effective measures have currently been shown to prevent the onset of the condition. However, it is important to recognise its symptoms, ensure appropriate clinical assessment and establish an early diagnosis. Once the condition has been diagnosed, individualised follow-up and adapting activities to each person's capacity may help manage symptoms and reduce the risk of post-exertional malaise.
General recommendations
Follow-up should be adapted to the severity and progression of the condition. Decisions about care and treatment should be made jointly by the person and their healthcare professionals, taking into account their needs, preferences and priorities.
Advice for patients with chronic pain, fibromyalgia, and chronic fatigue, from experts in the neuroscience of pain
Chronic fatigue syndrome
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.